愛博醫療(688050.SH)擬發行2629萬股 初步詢價時間為7月15日
格隆匯 7 月 9日丨愛博醫療(688050.SH)發佈首次公開發行股票並在科創板上市發行安排及初步詢價公告,擬公開發行股票數量為2629萬股,佔發行後公司總股本的25%,此次公開發行後公司總股本為10513.9272萬股。
此次發行初始戰略配售數量為394.35萬股,佔此次發行數量的15%,其中保薦機構相關子公司的預計跟投比例為公開發行股份的5%,即131.45萬股。最終戰略配售數量與初始戰略配售數量的差額將根據回撥機制規定的原則進行回撥。
回撥機制啟動前,網下初始發行數量為1570萬股,佔扣除初始戰略配售數量後發行數量的70.26%,網上初始發行數量為664.65萬股,佔扣除初始戰略配售數量後發行數量的29.74%。
最終網下、網上發行合計數量為此次發行總數量扣除最終戰略配售數量,網上最終發行數量及網下最終發行數量將根據回撥情況確定。
此次發行的初步詢價時間為2020年7月15日(T-3日)的9:30-15:00。網下投資者可使用CA證書登錄上交所申購平台網頁進行初步詢價。在上述時間內,符合條件的投資者可自主決定是否參與初步詢價,自行確定擬申購價格和擬申購數量。參與初步詢價的,須按照規定通過上交所申購平台統一申報,並自行承擔相應的法律責任。通過申購平台報價、查詢的時間為2020年7月15日上午9:30至下午15:00。
此次網下發行申購日與網上申購日同為2020年7月20日(T日),其中,網下申購時間為9:30-15:00,網上申購時間為9:30-11:30,13:00-15:00。投資者在2020年7月20日進行網上和網下申購時無需繳付申購資金及網下新股配售經紀佣金。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.